Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Depreciation & Amortization (CF) (2024 - 2025)

Beta Bionics' Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $573000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 146.98% year-over-year to $573000.0; the TTM value through Dec 2025 reached $1.6 million, up 36.66%, while the annual FY2025 figure was $1.6 million, 36.66% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $573000.0 at Beta Bionics, up from $400000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $573000.0 in Q4 2025 and bottomed at $232000.0 in Q4 2024.